Follow
Michael K Wendt
Michael K Wendt
Associate Professor of Pharmacology, Purdue University
Verified email at purdue.edu - Homepage
Title
Cited by
Cited by
Year
Mechanisms of the epithelial–mesenchymal transition by TGF-β
MK Wendt, TM Allington, WP Schiemann
Future Oncology 5 (8), 1145-1168, 2009
4062009
Phosphoproteins in extracellular vesicles as candidate markers for breast cancer
IH Chen, L Xue, CC Hsu, JSP Paez, L Pan, H Andaluz, MK Wendt, ...
Proceedings of the National Academy of Sciences 114 (12), 3175-3180, 2017
3772017
Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression
MK Wendt, M Tian, WP Schiemann
Cell and tissue research 347 (1), 85-101, 2012
2692012
Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer
MK Wendt, MA Taylor, BJ Schiemann, WP Schiemann
Molecular biology of the cell 22 (14), 2423-2435, 2011
2402011
Transforming growth factor-β-induced epithelial–mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression
MK Wendt, JA Smith, WP Schiemann
Oncogene 29 (49), 6485-6498, 2010
2262010
STAT3 and epithelial–mesenchymal transitions in carcinomas
MK Wendt, N Balanis, CR Carlin, WP Schiemann
Jak-stat 3 (2), e28975, 2014
2222014
Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-β signaling and metastasis
MK Wendt, WP Schiemann
Breast cancer research 11, 1-16, 2009
2042009
Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease
NP Zimmerman, RA Vongsa, MK Wendt, MB Dwinell
Inflammatory bowel diseases 14 (7), 1000-1011, 2008
1672008
Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis
MK Wendt, PA Johanesen, N Kang-Decker, DG Binion, V Shah, ...
Oncogene 25 (36), 4986-4997, 2006
1672006
Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells
MK Wendt, AN Cooper, MB Dwinell
Oncogene 27 (10), 1461-1471, 2008
1572008
Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway
N Balanis, MK Wendt, BJ Schiemann, Z Wang, WP Schiemann, CR Carlin
Journal of Biological Chemistry 288 (25), 17954-17967, 2013
1502013
The paradoxical functions of EGFR during breast cancer progression
R Ali, MK Wendt
Signal transduction and targeted therapy 2 (1), 1-7, 2017
1362017
CXCL12 activation of CXCR4 regulates mucosal host defense through stimulation of epithelial cell migration and promotion of intestinal barrier integrity
JM Smith, PA Johanesen, MK Wendt, DG Binion, MB Dwinell
American Journal of Physiology-Gastrointestinal and Liver Physiology 288 (2 …, 2005
1082005
Transglutaminase-2 facilitates extracellular vesicle-mediated establishment of the metastatic niche
A Shinde, JS Paez, S Libring, K Hopkins, L Solorio, MK Wendt
Oncogenesis 9 (2), 16, 2020
1032020
Spleen tyrosine kinase–mediated autophagy is required for epithelial–mesenchymal plasticity and metastasis in breast cancer
A Shinde, SD Hardy, D Kim, SS Akhand, MK Jolly, WH Wang, ...
Cancer research 79 (8), 1831-1843, 2019
1022019
Autocrine fibronectin inhibits breast cancer metastasis
A Shinde, S Libring, A Alpsoy, A Abdullah, JA Schaber, L Solorio, ...
Molecular cancer research 16 (10), 1579-1589, 2018
992018
Rho activation regulates CXCL12 chemokine stimulated actin rearrangement and restitution in model intestinal epithelia
RA Moyer, MK Wendt, PA Johanesen, JR Turner, MB Dwinell
Laboratory investigation 87 (8), 807-817, 2007
962007
Selection of DNA-encoded libraries to protein targets within and on living cells
B Cai, D Kim, S Akhand, Y Sun, RJ Cassell, A Alpsoy, EC Dykhuizen, ...
Journal of the American Chemical Society 141 (43), 17057-17061, 2019
942019
p130Cas is required for mammary tumor growth and transforming growth factor-β-mediated metastasis through regulation of Smad2/3 activity
MK Wendt, JA Smith, WP Schiemann
Journal of biological chemistry 284 (49), 34145-34156, 2009
892009
TGF-β stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer
MK Wendt, BJ Schiemann, JG Parvani, YH Lee, Y Kang, WP Schiemann
Oncogene 32 (16), 2005-2015, 2013
812013
The system can't perform the operation now. Try again later.
Articles 1–20